Byam Rebecca's Form 4 filing
HCW Biologics Inc. (HCWB) · filed Sep 14, 2022
- Accession no.
- 0001209191-22-049866
- Filed
- Sep 14, 2022
- Trade date
- Sep 12-13, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $78.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Byam RebeccaCIK 0001866256 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2022 | Common Stock | PPurchaseAcquired | +15,000 | $2.65 | +$39,750 | 297,952 | Direct | |
| Sep 13, 2022 | Common Stock | PPurchaseAcquired | +15,000 | $2.58 | +$38,700 | 312,952 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.